2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · Real-Time Price · USD
4.810
-0.170 (-3.41%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Company Description

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States.

The company’s products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma.

It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

2seventy bio, Inc.
2seventy bio logo
Country United States
Founded 2021
Industry Biotechnology
Sector Healthcare
Employees 274
CEO William Baird

Contact Details

Address:
60 Binney Street
Cambridge, Massachusetts 02142
United States
Phone 617 675 7270
Website 2seventybio.com

Stock Details

Ticker Symbol TSVT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001860782
CUSIP Number 901384107
ISIN Number US9013841070
Employer ID 86-3658454
SIC Code 2834

Key Executives

Name Position
William D. Baird III, M.B.A. Chief Executive Officer, President and Director
Victoria Eatwell Chief Financial Officer
Jessica Snow Senior Vice President of Quality and Head of Operations

Latest SEC Filings

Date Type Title
Sep 25, 2024 8-K Current Report
Aug 14, 2024 144 Filing
Aug 8, 2024 10-Q Quarterly Report
Aug 7, 2024 8-K Current Report
Jul 26, 2024 8-K Current Report
Jun 26, 2024 8-K Current Report
Jun 11, 2024 8-K Current Report
May 9, 2024 10-Q Quarterly Report
May 8, 2024 8-K Current Report
Apr 25, 2024 ARS Filing